Clinical Trials Browser

Phase 2 × Breast Neoplasms, Male × Epirubicin × Clear all

NCT00820547 2019-10-22

Beverly1

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00176488 2017-03-23

Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer

Phase 2 Terminated

31 enrolled 6 charts

Breast Neoplasms, Breast Neoplasms, Male